Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised a fund managed by the Private Equity Group on the deal. Ares Management Corporation (Ares), a leading global alternative investment manager,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised 888 Holdings Plc on the deal. 888 Holdings Plc closed its placing that raised gross proceeds of approximately £162.9 million. The...
You must be a Standard 1 Year member to access this content.
DLA Piper has advised John Menzies plc on the deal. Norton Rose Fulbright has advised Barclays. Latham & Watkins and Meysan Partners have advised Agility. John...
You must be a Standard 1 Year member to access this content.
Linklaters advised Caesars Entertainment, Inc. on the deal, while Herzog Fox & Neeman and Latham & Watkins advised 888 Holdings. White & Case advised J.P. Morgan...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Rothesay Life on the deal. Rothesay Life Plc closed two longevity reinsurance arrangements with MetLife, Inc. reinsuring approximately US$5 billion of pension liabilities...
You must be a Standard 1 Year member to access this content.
